3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Myelodysplastic Syndromes
1
Metabolism, Inborn Errors
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Immunologic Deficiency Syndromes
1
Hemoglobinopathies
1
Graft vs Host Disease
1
Congenital Bone Marrow Failure Syndromes
1
Carcinoma in Situ
1
Bone Marrow Failure Disorders
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Gemcitabine
57
130-nm albumin-bound paclitaxel
35
Specimen Handling
26
Magnetic Resonance Spectroscopy
21
Albumin-Bound Paclitaxel
21
Fluorouracil
20
Leucovorin
19
Irinotecan
19
Oxaliplatin
17
Biopsy
17
Taxes
16
pembrolizumab
13
Cyclophosphamide
11
Cisplatin
11
fludarabine
10
Cetuximab
9
Capecitabine
8
Nivolumab
7
Carboplatin
7
irinotecan sucrosofate
6
durvalumab
6
dehydroftorafur
6
Radiosurgery
6
Pemetrexed
6
olaparib
5
Ipilimumab
5
Erlotinib Hydrochloride
5
trastuzumab deruxtecan
4
aldesleukin
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Clinical Trials, Phase I as Topic
×
90 days
×
Clear all
No trials found.